EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors

Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, Phil F Cheng, Isaac F Hughes, Ester Simeone, Kamaneh Montazeri, Piyush Grover, Inderjit Mehmi, Camille L Gerard, Caroline Gaudy-Marqueste, Jean-Jacques Grob und 12 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2024.115161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Florentia Dimitriou und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electr…. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Immune Checkpoint Inhibitors, GTP-Binding Protein alpha Subunits, Gq-G11. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uveal NeoplasmsMelanomaImmune Checkpoint InhibitorsGTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Protein alpha SubunitsMutationHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and overUveal Melanoma

Stichwörter der Autor:innen

GNA11GNAQImmune checkpoint inhibitorsTebentafuspUveal melanoma

Substanzen

Immune Checkpoint InhibitorsGNAQ protein, humanGTP-Binding Protein alpha Subunits, Gq-G11GNA11 protein, humanGTP-Binding Protein alpha Subunits

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electronic address: florentia.dimitriou@usz.ch.
  • Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Departments of…
  • Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.

Zitieren

APA

Dimitriou, F., Orloff, M. M., Koch Hein, E. C., Cheng, P. F., Hughes, I. F., Simeone, E., Montazeri, K., Grover, P., Mehmi, I., Gerard, C. L., Gaudy-Marqueste, C., Grob, J. J., Michielin, O., Hamid, O., Long, G. V., Sullivan, R., Kapiteijn, E., Johnson, D. B., Ascierto, P. A., …, & Dummer, R. (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115161

Vancouver

Dimitriou F, Orloff MM, Koch Hein EC, Cheng PF, Hughes IF, Simeone E, et al. Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115161

BibTeX
@article{Dimitriou2025,
  author = {Dimitriou, Florentia and Orloff, Marlana M and Koch Hein, Erica C and Cheng, Phil F and Hughes, Isaac F and Simeone, Ester and Montazeri, Kamaneh and Grover, Piyush and Mehmi, Inderjit and Gerard, Camille L and Gaudy-Marqueste, Caroline and Grob, Jean-Jacques and Michielin, Olivier and Hamid, Omid and Long, Georgina V and Sullivan, Ryan and Kapiteijn, Ellen and Johnson, Douglas B and Ascierto, Paolo A and Joshua, Anthony M and Carvajal, Richard D and Butler, Marcus O and Hassel, Jessica C and Dummer, Reinhard},
  title = {Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2024.115161}
}
Kostenlos starten →